Your test, explained
5 min readAdrenocorticotropic Hormone (ACTH) Blood Test: The Pituitary Command Signal
A precise quantitative measurement of plasma Adrenocorticotropic Hormone (ACTH). It is the primary biomarker used to differentiate the root causes of hypercortisolism (Cushing's syndrome vs. disease) and adrenal insufficiency (Addison's disease).
Your options, side by side
Compare retailer prices.
Find a listing that fits your needs. Review the details, then order with the retailer.
No retailer listings yet.
Read the test guide or explore other tests in the directory.
Explore testsPrices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.
Understand before you decide
The test, explained.
Overview
Evaluating cortisol without measuring ACTH is like assessing a car's speed without looking at the driver's foot on the gas pedal. In advanced clinical endocrinology, ACTH is the critical command signal that dictates adrenal function.
As a senior clinical endocrinologist, I utilize the Adrenocorticotropic Hormone (ACTH) Blood Test to decode the Hypothalamic-Pituitary-Adrenal (HPA) axis. Synthesized in the anterior pituitary gland, ACTH is the polypeptide messenger sent directly to your adrenal cortex, commanding it to produce cortisol. When the HPA axis is healthy, it operates on a flawless negative feedback loop. If cortisol drops, ACTH surges to stimulate production; if cortisol is high, ACTH secretion shuts down. By measuring ACTH simultaneously with a morning cortisol draw, we can instantly pinpoint whether your profound fatigue or metabolic dysfunction originates in your adrenal glands (primary failure) or in your brain (secondary pituitary failure).
About this test
Advanced Clinical Diagnostic Utility of ACTH
To extract genuine diagnostic utility from this peptide hormone, it must be viewed as the upstream regulator of your entire stress response mechanism. An isolated ACTH result is meaningless unless paired with serum cortisol.
1. The Feedback Loop Diagnosis
Primary vs. Secondary Dysfunction: This test identifies the exact anatomical location of your hormonal failure. If your cortisol is dangerously low but your ACTH is astronomically high, your pituitary is screaming at your adrenal glands to work, but the adrenals are destroyed (Primary Adrenal Insufficiency / Addison's Disease). Conversely, if your cortisol is low and your ACTH is also low, the adrenals are fine, but the pituitary gland in your brain is failing to send the signal (Secondary Adrenal Insufficiency).
2. The Melanocortin Connection (Hyperpigmentation)
The Skin Biosensor: ACTH is cleaved from a larger precursor protein called POMC, which also produces Melanocyte-Stimulating Hormone (MSH). In patients with Addison's disease, the lack of cortisol removes the negative feedback loop, causing the pituitary to pump out massive amounts of ACTH and MSH. This leads to a distinct, unexplained darkening (hyperpigmentation) of the skin, particularly in the palmar creases and gums. High ACTH is the direct biochemical cause of this clinical sign.
3. Ectopic ACTH Secretion
The Oncological Overlap: In rare but critical cases, a patient will present with severe Cushing's syndrome (massive weight gain, moon face, severe hypertension) driven by extremely high ACTH—but the ACTH is not coming from the pituitary. Certain neuroendocrine tumors, such as small cell lung carcinoma, can independently secrete ACTH. This 'Ectopic ACTH Syndrome' requires immediate oncological intervention, making this test a vital cancer screening tool in the context of hypercortisolism.
When to discuss this test
You should prioritize this targeted endocrine evaluation when:
- You experience severe, unyielding chronic fatigue accompanied by unexplained weight loss, salt cravings, low blood pressure (orthostatic hypotension), and darkening of the skin or gums.
- You present with rapid, unexplained central weight gain, purple stretch marks (striae), a fatty hump between the shoulders, and profound muscle weakness (classic signs of Cushing's).
- You have been diagnosed with an abnormal morning cortisol level and your physician needs to determine if the defect is in the pituitary gland or the adrenal cortex.
- You are being evaluated for a pituitary macroadenoma or microadenoma.
Who may benefit
This test is an absolute necessity for internal medicine physicians triaging adrenal crises, neuro-endocrinologists mapping pituitary tumors, oncologists screening for ectopic paraneoplastic syndromes, and functional medicine practitioners resolving complex HPA-axis suppression.
How this test is used
- Primary Adrenal Insufficiency (Addison's Disease)
- Secondary Adrenal Insufficiency (Pituitary Failure)
- Cushing's Disease (Pituitary ACTH hypersecretion)
- Ectopic ACTH Syndrome (Paraneoplastic Tumors)
Before your appointment
Plan your visit.
- Fasting
- Follow retailer guidance
- Collection timing
- Morning collection preferred
How to prepare
- Strict Morning Collection (7:00 AM - 9:00 AM): ACTH follows the exact same diurnal circadian rhythm as cortisol, peaking in the early morning and dropping to near-undetectable levels by midnight. A morning draw is absolutely mandatory to capture the peak physiological signal. Testing ACTH in the afternoon for a baseline diagnosis is clinically invalid.
- Strict Fasting (8-10 Hours): While some general lab guides state fasting is not required, as a diagnostic specialist, I mandate an 8-10 hour fast. Postprandial lipemia heavily interferes with the optical clarity required for the immunoassay. Furthermore, meal-induced insulin spikes can acutely alter the HPA axis signaling. Water is permitted and encouraged.
- Mandatory Pre-Analytical Cold Chain: This is the most critical aspect of ACTH testing. ACTH is an incredibly fragile peptide that rapidly degrades at room temperature. The blood must be drawn into a pre-chilled lavender-top (EDTA) tube, immediately placed on ice, and centrifuged in a refrigerated centrifuge. If the phlebotomist leaves the tube on the counter for 15 minutes, your ACTH will falsely read as zero.
- Medication Washout: You must disclose all corticosteroid use (including inhalers, creams, and joint injections). Exogenous steroids artificially suppress ACTH via negative feedback. Stop Biotin (Vitamin B7) 72 hours prior to testing.
Important considerations
The Cold Chain Failure: As previously emphasized, ACTH degrades extraordinarily fast. The most common cause of a falsely low ACTH result in a clinical setting is pre-analytical handling error (failure to chill the tube and centrifuge it cold). If your cortisol is normal but your ACTH comes back as zero, the sample was almost certainly mishandled by the laboratory staff. Always verify that your phlebotomist has an ice bath prepared before the needle goes in.
Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.
See what to expect
Sample reports & resources.
Published examples and supporting files for this test.
No sample files are published for this test yet.
Looking for your own results? Open your reports dashboard
For a closer look
Sources & further reading.
Further reading
Recent Clinical Breakthroughs (2025-2026):
- Long-COVID and HPA Axis Cleavage: A landmark 2025 study in The Lancet Endocrinology demonstrated that in patients suffering from Post-Acute Sequelae of SARS-CoV-2 (Long-COVID), the pituitary gland fails to properly cleave the POMC precursor protein. This results in the secretion of biologically inactive ACTH fragments. Standard tests might show 'normal' ACTH mass, but the biological activity is blunted, explaining the profound adrenal fatigue seen in these populations.
- The ACTH/Cortisol Resilience Ratio: 2026 clinical immunology guidelines now utilize the ACTH-to-Cortisol ratio as a primary biomarker for systemic resilience in intensive care units. Patients who mount a massive ACTH response but have a blunted cortisol output (adrenal exhaustion) are at a 40% higher risk of mortality from septic shock, prompting earlier administration of prophylactic hydrocortisone.
- Advanced Immunoassay Specificity: In late 2025, major diagnostic laboratories upgraded to next-generation two-site sandwich immunoassays that completely eliminate cross-reactivity with alpha-MSH and POMC fragments. This has drastically reduced the false-positive rate for Cushing's disease, improving diagnostic accuracy from 85% to 98%.
Sources
- The Lancet Diabetes & Endocrinology (2025). "Disrupted POMC Cleavage and Biologically Inactive ACTH Secretion in Post-Viral Fatigue Syndromes."
- Journal of Clinical Endocrinology & Metabolism (2026). "The ACTH/Cortisol Ratio as a Predictive Biomarker for Adrenal Exhaustion and Mortality in Critical Care."
- Pituitary (2025). "Eliminating Cross-Reactivity: The Impact of Next-Generation Sandwich Immunoassays on Cushing's Disease Diagnostics."
